TRLs and theirmetabolites are involved in the pathogenesis of atherosclerosis by modulatinginflammation, oxidative stress, and foam cell formation [87], as well as inducingcell proliferation [88] and monocyte chemoattractant protein-1 (MCP-1) expressionin SMCs [89]. The gene discussed is CCL2; the disease is atherosclerosis.